Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia

BACKGROUND: Currently, there is lack of marker to accurately assess the prognosis of patients diagnosed with pancreatic ductal adenocarcinoma (PDAC). This study aims to establish a hypoxia-related risk scoring model that can effectively predict the prognosis and chemotherapy outcomes of PDAC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Min, Feng, Liaoliao, Zong, Rongrong, Sun, Huiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464224/
https://www.ncbi.nlm.nih.gov/pubmed/37605192
http://dx.doi.org/10.1186/s12957-023-03142-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464224/
https://www.ncbi.nlm.nih.gov/pubmed/37605192
http://dx.doi.org/10.1186/s12957-023-03142-2

Ejemplares similares